Home4582 • TYO
add
Symbio Pharmaceuticals Ltd
Previous close
¥114.00
Day range
¥113.00 - ¥116.00
Year range
¥112.00 - ¥262.00
Market cap
6.16B JPY
Avg Volume
642.19K
P/E ratio
-
Dividend yield
-
Primary exchange
TYO
Market news
Financials
Income Statement
Revenue
Net income
| (JPY) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 324.17M | -47.20% |
Operating expense | 1.39B | -8.71% |
Net income | -1.20B | 8.22% |
Net profit margin | -369.09 | -73.81% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | 0.30% | — |
Balance Sheet
Total assets
Total liabilities
| (JPY) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.46B | -32.47% |
Total assets | 4.58B | -24.52% |
Total liabilities | 2.93B | 221.61% |
Total equity | 1.65B | — |
Shares outstanding | 51.95M | — |
Price to book | 3.58 | — |
Return on assets | -67.97% | — |
Return on capital | -77.41% | — |
Cash Flow
Net change in cash
| (JPY) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.20B | 8.22% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
Mar 25, 2005
Headquarters
Website
Employees
108
